Colorectal Cancer and IBD
People with IBD are at increased
risk for developing colorectal
cancer. Specific risk factors
include having:
-
IBD for 8 years or
longer
-
Extensive colon
involvement
-
Extensive inflammation
of the colon
-
Bile duct inflammation
-
Polyps or precancerous
changes in the colon or
rectum
-
Colorectal cancer in a
family member
Current guidelines recommend
that people with IBD undergo
earlier and more frequent
screening for colorectal cancer
than people who do not have IBD.
Do you have IBD?
If you have IBD and are unsure
about colorectal cancer
screening, talk with one of our
gastroenterologists.To schedule
an appointment:
|
Inflammatory bowel disease (IBD) is characterized by chronic intestinal
inflammation that is triggered by abnormal immune response. The two main
forms of IBD are:
Inflammation usually is a normal process that occurs when the immune
system is fighting to protect the body. In IBD, the immune system
mistakenly attacks the digestive tract, producing harmful inflammation.
It is unclear what triggers the attack, but the cause of IBD is thought
to involve genetic, environmental, and immune system factors.
IBD usually requires lifelong treatment with medications and, at times,
surgery. Fortunately, advances in medical therapy are making it
increasingly possible to achieve and maintain disease remission (control
of inflammation and absence of symptoms). The earlier IBD is diagnosed
and brought under control, the more likely it is to avoid damage to the
digestive tract.
Why Choose Lankenau?
Our physician team for IBD
includes gastroenterologists experienced with the latest medical
treatments for IBD and surgeons skilled in both complex and minimally
invasive procedures, should surgery be necessary. Our physicians are
committed to helping people with IBD take control of their disease and
live normal, active lives.
To schedule an appointment with a Lankenau
gastroenterologist, call 866.CALL.MLH or use the online
appointment request form.
.jpg)
